Tags

Type your tag names separated by a space and hit enter

Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
Gut. 1982 Jul; 23(7):621-4.Gut

Abstract

Fifty patients with endoscopically proven gastric ulcers completed a one month double-blind randomised trial of tripotassium dicitrato bismuthate (TBD) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in nine (36%) of the patients given placebo. The TDB group experienced significantly less pain than the placebo group. During a follow-up of 29 patients with healed ulcers for up to 44 months, relapse occurred in 13 (45%). It was highest in the first three months (27%) and had risen to 41% at two years.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7044913

Citation

Sutton, D R.. "Gastric Ulcer Healing With Tripotassium Dicitrato Bismuthate and Subsequent Relapse." Gut, vol. 23, no. 7, 1982, pp. 621-4.
Sutton DR. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Gut. 1982;23(7):621-4.
Sutton, D. R. (1982). Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Gut, 23(7), 621-4.
Sutton DR. Gastric Ulcer Healing With Tripotassium Dicitrato Bismuthate and Subsequent Relapse. Gut. 1982;23(7):621-4. PubMed PMID: 7044913.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. A1 - Sutton,D R, PY - 1982/7/1/pubmed PY - 1982/7/1/medline PY - 1982/7/1/entrez SP - 621 EP - 4 JF - Gut JO - Gut VL - 23 IS - 7 N2 - Fifty patients with endoscopically proven gastric ulcers completed a one month double-blind randomised trial of tripotassium dicitrato bismuthate (TBD) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in nine (36%) of the patients given placebo. The TDB group experienced significantly less pain than the placebo group. During a follow-up of 29 patients with healed ulcers for up to 44 months, relapse occurred in 13 (45%). It was highest in the first three months (27%) and had risen to 41% at two years. SN - 0017-5749 UR - https://www.unboundmedicine.com/medline/citation/7044913/Gastric_ulcer_healing_with_tripotassium_dicitrato_bismuthate_and_subsequent_relapse_ L2 - https://gut.bmj.com/lookup/pmidlookup?view=long&pmid=7044913 DB - PRIME DP - Unbound Medicine ER -